Literature DB >> 21221816

Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada.

Daria J O'Reilly1, Feng Xie, Eleanor Pullenayegum, Hertzel C Gerstein, Janet Greb, Gord K Blackhouse, Jean-Eric Tarride, Jim Bowen, Ron A Goeree.   

Abstract

OBJECTIVES: The goal of this study was to analyze health-related quality of life (HRQL) data from a Canadian population with type 2 diabetes in order to estimate the disutility associated with experiencing a diabetes-related complication.
METHODS: The EQ-5D, a standardized instrument for use as a measure of health outcome, was administered to 1,147 patients in Hamilton, Ontario, with type 2 diabetes. After controlling for age, gender, and duration of diabetes, changes in utility values were estimated by regressing the EQ-5D scores onto binary indicators for the presence of an event. The primary method of analysis was Ordinary Least Squares (OLS) and due to concerns over non-Normality, bootstrap standard errors (SE) were calculated.
RESULTS: The analysis included 1,143 participants. Based on the OLS model, reductions in HRQL were associated with duration of diabetes (-0.0015, SE = 0.0006), experiencing a myocardial infarction (MI) (-0.059, SE = 0.017), amputation (-0.063, SE = 0.059), stroke (-0.046, SE = 0.023), and kidney failure (-0.102, SE = 0.047).
CONCLUSION: This study estimated the reductions in HRQL associated with several important complications commonly experienced in patients with diabetes. The greatest impacts on HRQL were associated with kidney failure and MI. The utility values calculated here can be used to assess the outcome of interventions that reduce these diabetes-related complications and will have a useful impact on future economic evaluations of diabetes management strategies in Canada.

Entities:  

Mesh:

Year:  2011        PMID: 21221816     DOI: 10.1007/s11136-010-9828-9

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  25 in total

Review 1.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

2.  Valuations of EQ-5D health states: are the United States and United Kingdom different?

Authors:  Jeffrey A Johnson; Nan Luo; James W Shaw; Paul Kind; Stephen Joel Coons
Journal:  Med Care       Date:  2005-03       Impact factor: 2.983

3.  Preference-Based EQ-5D index scores for chronic conditions in the United States.

Authors:  Patrick W Sullivan; Vahram Ghushchyan
Journal:  Med Decis Making       Date:  2006 Jul-Aug       Impact factor: 2.583

Review 4.  Quality of life and diabetes.

Authors:  R R Rubin; M Peyrot
Journal:  Diabetes Metab Res Rev       Date:  1999 May-Jun       Impact factor: 4.876

5.  Valuing health-related quality of life in diabetes.

Authors:  J Todd Coffey; Michael Brandle; Honghong Zhou; Deanna Marriott; Ray Burke; Bahman P Tabaei; Michael M Engelgau; Robert M Kaplan; William H Herman
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

6.  Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data.

Authors:  Adrian Bagust; Sophie Beale
Journal:  Health Econ       Date:  2005-03       Impact factor: 3.046

7.  A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes.

Authors:  Sheri L Maddigan; David H Feeny; Jeffrey A Johnson
Journal:  Med Decis Making       Date:  2003 Nov-Dec       Impact factor: 2.583

8.  Health-related quality of life in type 2 diabetes (TARDIS-2).

Authors:  J Holmes; S McGill; P Kind; J Bottomley; S Gillam; M Murphy
Journal:  Value Health       Date:  2000 Nov-Dec       Impact factor: 5.725

9.  Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996-1997.

Authors:  Douglas G Manuel; Susan E Schultz
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

10.  Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial.

Authors:  Paul Glasziou; Jan Alexander; Elaine Beller; Philip Clarke
Journal:  Health Qual Life Outcomes       Date:  2007-04-27       Impact factor: 3.186

View more
  22 in total

1.  Health-related quality of life and health utilities in insulin-treated type 2 diabetes: the impact of related comorbidities/complications.

Authors:  John Yfantopoulos; Athanasios Chantzaras
Journal:  Eur J Health Econ       Date:  2020-03-03

2.  HRQOL in Diverse Ethnic Groups with Diabetes: Findings from the 2014 BRFSS.

Authors:  Kelley Newlin Lew; Julie Wagner; Omar Braizat
Journal:  J Racial Ethn Health Disparities       Date:  2018-03-14

3.  Quality of life along the diabetes continuum: a cross-sectional view of health-related quality of life and general health status in middle-aged and older Finns.

Authors:  Saku Väätäinen; Sirkka Keinänen-Kiukaanniemi; Jouko Saramies; Hannu Uusitalo; Jaakko Tuomilehto; Janne Martikainen
Journal:  Qual Life Res       Date:  2014-02-08       Impact factor: 4.147

4.  Comorbidity, health-related quality of life and self-care in type 2 diabetes: a cross-sectional study in an outpatient population.

Authors:  M P O'Shea; M Teeling; K Bennett
Journal:  Ir J Med Sci       Date:  2014-08-29       Impact factor: 1.568

5.  Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial.

Authors:  Dennis W Raisch; Patricia Feeney; David C Goff; K M Venkat Narayan; Patrick J O'Connor; Ping Zhang; Don G Hire; Mark D Sullivan
Journal:  Cardiovasc Diabetol       Date:  2012-07-11       Impact factor: 9.951

6.  Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.

Authors:  Mehdi Javanbakht; Atefeh Mashayekhi; Hamid R Baradaran; AliAkbar Haghdoost; Ashkan Afshin
Journal:  PLoS One       Date:  2015-07-22       Impact factor: 3.240

7.  Health related quality of life in patients with type 2 diabetes mellitus in Iran: a national survey.

Authors:  Mehdi Javanbakht; Farid Abolhasani; Atefeh Mashayekhi; Hamid R Baradaran; Younes Jahangiri noudeh
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

8.  Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany--a retrospective cohort and case control study in claims data of a large statutory health insurance.

Authors:  Michael W J Boehme; Gisela Buechele; Julia Frankenhauser-Mannuss; Jana Mueller; Dietlinde Lump; Bernhard O Boehm; Dietrich Rothenbacher
Journal:  BMC Public Health       Date:  2015-09-03       Impact factor: 3.295

9.  A cross-sectional assessment of health-related quality of life among type 2 diabetes patients in Riyadh, Saudi Arabia.

Authors:  Ibrahim Suliman Al-Aboudi; Mohamed Azmi Hassali; Asrul Akmal Shafie; Asim Hassan; Alian A Alrasheedy
Journal:  SAGE Open Med       Date:  2015-10-09

10.  Diabetes mellitus and intermittent claudication: a cross-sectional study of 920 claudicants.

Authors:  Francisco S Lozano; José R González-Porras; José R March; José M Lobos; Eduardo Carrasco; Eduardo Ros
Journal:  Diabetol Metab Syndr       Date:  2014-02-17       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.